The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-hydroxy-N-1-(1R)-1-methylsulfanyl-2-[5-[2-[4-(morpholinomethyl]phenyl]ethynyl]benzotriazol-1-yl]ethyl]formamide ID: ALA4763862
PubChem CID: 162660909
Max Phase: Preclinical
Molecular Formula: C23H25N5O3S
Molecular Weight: 451.55
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CS[C@H](Cn1nnc2cc(C#Cc3ccc(CN4CCOCC4)cc3)ccc21)N(O)C=O
Standard InChI: InChI=1S/C23H25N5O3S/c1-32-23(28(30)17-29)16-27-22-9-8-19(14-21(22)24-25-27)5-2-18-3-6-20(7-4-18)15-26-10-12-31-13-11-26/h3-4,6-9,14,17,23,30H,10-13,15-16H2,1H3/t23-/m1/s1
Standard InChI Key: VVTZCIBPJIURIN-HSZRJFAPSA-N
Molfile:
RDKit 2D
32 35 0 0 0 0 0 0 0 0999 V2000
9.1980 -18.9655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1969 -19.7928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9117 -20.2057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9098 -18.5528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4821 -20.2048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7620 -20.6113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0437 -21.0169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3362 -20.5933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6184 -20.9982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6100 -21.8239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3254 -22.2432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0403 -21.8358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8921 -22.2305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1811 -21.8121 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1878 -20.9872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4810 -20.5689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7607 -20.9719 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.7519 -21.7978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4633 -22.2207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6252 -18.9619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6300 -19.7883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4175 -20.0391 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.8994 -19.3676 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.4096 -18.7021 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.6600 -17.9160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4659 -17.7397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7162 -16.9536 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.5221 -16.7774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7724 -15.9914 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.1606 -16.3439 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.0215 -18.3495 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
12.7712 -19.1355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 21 1 0
20 4 1 0
4 1 2 0
2 5 1 0
5 6 3 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
10 13 1 0
13 14 1 0
14 15 1 0
14 19 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 20 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 29 2 0
27 30 1 0
26 31 1 6
31 32 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 451.55Molecular Weight (Monoisotopic): 451.1678AlogP: 2.20#Rotatable Bonds: 7Polar Surface Area: 83.72Molecular Species: NEUTRALHBA: 8HBD: 1#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.88CX Basic pKa: 6.73CX LogP: 2.97CX LogD: 3.01Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.19Np Likeness Score: -1.49
References 1. Furuya T,Shapiro AB,Comita-Prevoir J,Kuenstner EJ,Zhang J,Ribe SD,Chen A,Hines D,Moussa SH,Carter NM,Sylvester MA,Romero JAC,Vega CV,Sacco MD,Chen Y,O'Donnell JP,Durand-Reville TF,Miller AA,Tommasi RA. (2020) N-Hydroxyformamide LpxC inhibitors, their in vivo efficacy in a mouse Escherichia coli infection model, and their safety in a rat hemodynamic assay., 28 (24): [PMID:33160146 ] [10.1016/j.bmc.2020.115826 ]